z-logo
open-access-imgOpen Access
The revolution of lung cancer treatment: from vaccines, to immune checkpoint inhibitors, to chimeric antigen receptor T therapy
Author(s) -
Yingcheng Wu,
Maorong Jiang
Publication year - 2017
Publication title -
biotarget
Language(s) - English
Resource type - Journals
ISSN - 2522-669X
DOI - 10.21037/biotarget.2017.05.02
Subject(s) - chimeric antigen receptor , lung cancer , immunology , antigen , medicine , immune checkpoint , immune system , immunotherapy , cancer research , cancer , virology , oncology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom